These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 10209953

  • 1. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes.
    Oiso M, Eura M, Katsura F, Takiguchi M, Sobao Y, Masuyama K, Nakashima M, Itoh K, Ishikawa T.
    Int J Cancer; 1999 May 05; 81(3):387-94. PubMed ID: 10209953
    [Abstract] [Full Text] [Related]

  • 2. A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.
    Miyagawa N, Kono K, Mimura K, Omata H, Sugai H, Fujii H.
    Oncology; 2006 May 05; 70(1):54-62. PubMed ID: 16446550
    [Abstract] [Full Text] [Related]

  • 3. Analysis of individual specific cytotoxic T lymphocytes for two MAGE-3-derived epitopes presented by HLA-A24.
    Katsura F, Eura M, Chikamatsu K, Oiso M, Yumoto E, Ishikawa T.
    Jpn J Clin Oncol; 2000 Mar 05; 30(3):117-21. PubMed ID: 10798537
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes.
    Tahara K, Takesako K, Sette A, Celis E, Kitano S, Akiyoshi T.
    Clin Cancer Res; 1999 Aug 05; 5(8):2236-41. PubMed ID: 10473111
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.
    Akiyama Y, Maruyama K, Tai S, Komiyama M, Iizuka A, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K.
    Anticancer Res; 2009 Feb 05; 29(2):647-55. PubMed ID: 19331215
    [Abstract] [Full Text] [Related]

  • 9. Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules.
    So T, Hanagiri T, Chapiro J, Colau D, Brasseur F, Yasumoto K, Boon T, Coulie PG.
    Cancer Immunol Immunother; 2007 Feb 05; 56(2):259-69. PubMed ID: 16758204
    [Abstract] [Full Text] [Related]

  • 10. Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24.
    Tanaka F, Fujie T, Tahara K, Mori M, Takesako K, Sette A, Celis E, Akiyoshi T.
    Cancer Res; 1997 Oct 15; 57(20):4465-8. PubMed ID: 9377553
    [Abstract] [Full Text] [Related]

  • 11. A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes.
    Fujie T, Tahara K, Tanaka F, Mori M, Takesako K, Akiyoshi T.
    Int J Cancer; 1999 Jan 18; 80(2):169-72. PubMed ID: 9935194
    [Abstract] [Full Text] [Related]

  • 12. Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs.
    Mimura K, Kono K, Southwood S, Fikes J, Takahashi A, Miyagawa N, Sugai H, Fujii H.
    Cancer Immunol Immunother; 2006 Nov 18; 55(11):1358-66. PubMed ID: 16435129
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
    Chaux P, Luiten R, Demotte N, Vantomme V, Stroobant V, Traversari C, Russo V, Schultz E, Cornelis GR, Boon T, van der Bruggen P.
    J Immunol; 1999 Sep 01; 163(5):2928-36. PubMed ID: 10453041
    [Abstract] [Full Text] [Related]

  • 18. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D, Liénard D, Waanders G, Rimoldi D, Cerottini JC, Romero P.
    Cancer Res; 1997 Feb 15; 57(4):735-41. PubMed ID: 9044853
    [Abstract] [Full Text] [Related]

  • 19. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
    Umano Y, Tsunoda T, Tanaka H, Matsuda K, Yamaue H, Tanimura H.
    Br J Cancer; 2001 Apr 20; 84(8):1052-7. PubMed ID: 11308253
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.